enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]

  3. Cereblon E3 ligase modulator - Wikipedia

    en.wikipedia.org/wiki/Cereblon_E3_ligase_modulator

    The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.

  4. Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now ... - AOL

    www.aol.com/news/2013-06-17-oral-anti-cancer...

    Oral Anti-Cancer Therapy REVLIMID ® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease Treatment indicated for patients with transfusion-dependent anaemia ...

  5. Celgene - Wikipedia

    en.wikipedia.org/wiki/Celgene

    In December 2005, Celgene received approval from the FDA to market Revlimid for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Focalin XR was later launched by Celgene and Novartis in 2005.

  6. Why a Cancer Patient Who Met Kate Middleton Says, 'We ... - AOL

    www.aol.com/lifestyle/why-cancer-patient-met...

    Kate Middleton's visit to a London hospital where she had cancer treatment last year made a real impact, but one cancer patient says there's no need for the royal to disclose her diagnosis.

  7. Celgene's Revlimid Faces a Tough Sell - AOL

    www.aol.com/2013/11/18/celgenes-revlimid-faces-a...

    When it comes to drug pricing, European regulators are a tough sell. Just ask Johnson & Johnson . The U.K.'s National Institute for Health and Care Excellence, or NICE, took a pass on paying for ...

  8. Oncolytics Biotech - Wikipedia

    en.wikipedia.org/wiki/Oncolytics_Biotech

    In March 2017, the company announced positive overall survival data from the open-label, randomized study where, in the intention-to-treat patient population, there was a statistically significant improvement in median overall survival from 10.4 months on the control arm to 17.4 months on the test arm. [26]

  9. US accuses CVS of filling, billing government for illegal ...

    www.aol.com/news/us-accuses-cvs-filling-billing...

    (Reuters) -The U.S. Department of Justice announced a lawsuit on Wednesday accusing pharmacy chain CVS of filling illegal opioid prescriptions and billing federal health insurance programs ...